NASDAQ:TORC - resTORbio Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$7.25
▼ -0.02 (-0.28%)
Get New resTORbio Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TORC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TORC

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for resTORbio in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $7.25.

This chart shows the closing price for TORC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in resTORbio. This rating has held steady since May 2021, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
2/12/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/12/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/10/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/28/2020FIG PartnersReiterated RatingReduceHigh
4/29/2020Evercore ISIUpgradeIn-Line ➝ Outperform$2.00 ➝ $4.00High
11/15/2019SVB LeerinkDowngradeOutperform ➝ Market PerformHigh
11/15/2019WedbushDowngradeOutperform ➝ NeutralN/A
11/15/2019GuggenheimDowngradeBuy ➝ NeutralN/A
11/15/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$23.00 ➝ $3.00N/A
9/9/2019Cantor FitzgeraldInitiated CoverageOverweight$23.00Low
6/4/2019GuggenheimInitiated CoverageBuy ➝ Buy$28.00High
3/25/2019SVB LeerinkReiterated RatingOutperformMedium
3/18/2019WedbushReiterated RatingOutperformHigh
8/1/2018Evercore ISIReiterated RatingOutperform ➝ In-LineLow
2/20/2018SVB LeerinkInitiated CoverageOutperform ➝ Outperform$36.00High
2/20/2018WedbushInitiated CoverageOutperform$30.00High
2/20/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$23.00High
2/20/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$28.00High
(Data available from 8/5/2016 forward)
resTORbio logo
Adicet Bio, Inc. is a biotechnology company which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Read More

Today's Range

Now: $7.25
Low: $7.05
High: $7.40

50 Day Range

MA: $12.16
Low: $2.28
High: $14.77

52 Week Range

Now: $7.25
Low: $0.86
High: $10.50

Volume

70,346 shs

Average Volume

1,153,737 shs

Market Capitalization

$264.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.43

Frequently Asked Questions

What sell-side analysts currently cover shares of resTORbio?

The following Wall Street analysts have issued stock ratings on resTORbio in the last year:
View the latest analyst ratings for TORC.

What is the current price target for resTORbio?

0 Wall Street analysts have set twelve-month price targets for resTORbio in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for resTORbio in the next year.
View the latest price targets for TORC.

What is the current consensus analyst rating for resTORbio?

resTORbio currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for TORC.

What other companies compete with resTORbio?

How do I contact resTORbio's investor relations team?

resTORbio's physical mailing address is 500 BOYLSTON STREET 13TH FLOOR, BOSTON MA, 02116. The company's listed phone number is (857) 315-5521. The official website for resTORbio is www.restorbio.com.